Showing results (41-50 of 47) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Journal of the National Cancer Institute|May 6, 2024
Ataxia telangiectasia and Rad3-related (ATR) inhibitor camonsertib dose optimization in patients with biomarker-selected advanced solid tumors (TRESR study)Elisa Fontana, Ezra Rosen, Elizabeth K Lee, et al.Frontiers in Digital Health|December 15, 2025
UpSMART: five years of digital innovation in cancer clinical research-achievements, challenges, and recommendationsPaul O'Regan, Fouziah Butt, Louise Carter, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 6, 2025
First-in-Human, Phase I/II Dose Escalation and Expansion Study of Zelenectide Pevedotin in Patients With Advanced Solid Tumors: Results From Monotherapy Dose EscalationCapucine Baldini, Loic Verlingue, Vincent Goldschmidt, et al.Nature Cancer|February 5, 2022
A biobank of small cell lung cancer CDX models elucidates inter- and intratumoral phenotypic heterogeneityKathryn L Simpson, Ruth Stoney, Kristopher K Frese, et al.Nature Medicine|June 2, 2014
Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancerCassandra L Hodgkinson, Christopher J Morrow, Yaoyong Li, et al.Nature Medicine|June 5, 2023
Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial resultsTimothy A Yap, Elisa Fontana, Elizabeth K Lee, et al.Nature Medicine|April 24, 2019
Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET studyDominic G Rothwell, Mahmood Ayub, Natalie Cook, et al.Pageof 5